Crestline Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-46,779
| Closed | -$4.32M | – | 253 |
|
|
2024
Q4 | $4.32M | Buy |
46,779
+5,875
| +14% | +$543K | 0.14% | 158 |
|
|
2024
Q3 | $3.43M | Buy |
+40,904
| New | +$3.43M | 0.18% | 137 |
|
|
2019
Q4 | – | Sell |
-50,000
| Closed | -$3.17M | – | 66 |
|
|
2019
Q3 | $3.17M | Buy |
50,000
+32,000
| +178% | +$2.03M | 0.51% | 35 |
|
|
2019
Q2 | $1.22M | Buy |
+18,000
| New | +$1.22M | 0.16% | 57 |
|
|
2018
Q3 | – | Sell |
-20,840
| Closed | -$1.48M | – | 180 |
|
|
2018
Q2 | $1.48M | Buy |
+20,840
| New | +$1.48M | 0.16% | 168 |
|
|
2017
Q3 | – | Sell |
-50,881
| Closed | -$3.6M | – | 143 |
|
|
2017
Q2 | $3.6M | Buy |
50,881
+28,881
| +131% | +$2.04M | 0.48% | 15 |
|
|
2017
Q1 | $1.49M | Buy |
+22,000
| New | +$1.49M | 0.27% | 40 |
|
|
2016
Q4 | – | Sell |
-10,714
| Closed | -$848K | – | 129 |
|
|
2016
Q3 | $848K | Buy |
+10,714
| New | +$848K | 0.11% | 100 |
|